Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Neo-N Clinical Trial Update
BCT 1902: Neo-N Description Neo-N is an International clinical trial which will enrol up to…
Molecules in urine allow doctors to monitor skin cancer
What if you could simply provide a urine sample rather than undergo a painful surgical…
New approach for calculating radiation dosimetry allows for individualized therapy
Researchers have developed a simplified process that could enhance personalisation of cancer therapy based on…
New “beacon” method detects cancer recurrence
By Caleb Radford – The Lead SA. A new detection method for tumour recurrence in bowel cancer patients is proving to…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.